Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'

Br J Dermatol. 2014 Jul;171(1):15-6. doi: 10.1111/bjd.13075.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Humans
  • Male
  • Pruritus / drug therapy*
  • Urticaria / drug therapy*

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized